Monday, 2 March 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 2 March 2026
Vivacity
Vivacity
BMS scores world first PBS win

The Federal Government has claimed a world first for the multi-indication PBS listing this month of BMS' blockbuster immunotherapy drugs, marking a major breakthrough in the way medicines are funded in Australia.

10 pharmas win March PBS listings
Companies win March PBS listings, with some even securing subsidy for more than one drug or for multiple indications
TODAY New to the PBS
First rival for antipsychotic med
First generic of an antipsychotic medicine approved plus a new drug strength for an Astellas medicine which won a PBAC nod last year
TODAY Approvals Action
Hundreds apply for this pharma job
Recruiters are being swamped with applicants but it takes them just six to eight seconds to determine who makes the shortlist
27 February
Sales are booming for these drugs
Just a dozen drugs accounted for almost half of the increased R/PBS spending in 2025, as innovation become available to patients
27 February
Global piles on pressure for growth
How ANZ leaders can meet growth expected by boards, global leadership and shareholders despite squeezed budgets
26 February
Oncologists rank favourite pharmas
Perception survey reveals HCPs in oncology favour pharmas with a broad portfolio of drugs rather than a single blockbuster
25 February
PiF Jobs
PiF Jobs
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (10)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (5)

Devices (1)

Executive Roles (3)

Other (17)

Pharma year kicks off at full burn
ICYMI: Industry feeling the strain of working multiple roles and working long hours plus the other most popular stories this week
27 February Your Week in 5 Minutes
Rookie outshines blockbuster
This newcomer has shown superiority to one of the world's biggest drugs, adding another competitor to an already hot market
27 February
Call for action on rare disease
Organisations across Asia Pacific have joined MSD in calling for action on a rare disease that affects thousands of Australians
27 February
Aussie leader wins global award
Recognised with the highest honour for not only delivering excellence but for building community, elevating others, and driving impact
26 February
Aussie market next for pain drug
Non-opioid pain patch marketed in the US and Europe headed Down Under following new licensing agreement
26 February
Aussie execs landing new roles
New hires, big promotions plus a well-known leader launches an advisory firm in the latest employment moves across pharma
26 February
Putting patients before business
Global pharma employees paused their daily schedule to contemplate the company's values in decision-making
25 February
Hyped drug fails to reach Aust
Company voluntarily pulls drug accepted for TGA review in 2023, from all markets after an uphill commercialisation battle
26 February
TGA targets pharma for millions
The regulator believes the pharma industry owes it tens of millions of dollars, and it's looking at ways to collect
25 February
Aussie 1st-to-market race heats up
Another 'No' for reimbursement tightens the race to launch the first oral SERD in Australia, with three companies in the running
25 February
Gilead inks US$7.8B buyout
Setting up a red-hot rivalry with Johnson & Johnson and BMS in a hard-fought therapy space and it's ready to move 'with speed'
25 February
2026 burnout takes hold... already
Just seven weeks into the year and pharma employees are already buckling under the strain of working multiple roles and long hours
24 February
Novo's big hope fails against Lilly
Much hyped combo for obesity found to be less effective than Lilly's obesity blockbuster, sending the share price tumbling
24 February
Arrotex inks fresh licensing deal
Company forges path into the innovative medicines space announcing an exclusive licensing deal with a Taiwan-based pharma
24 February
PiF advertise
PiF advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.